{"hq_id":"hq-p-bdy-000137","name":"Fertility Treatment Medications (Hormones, Endocrine Disruption Paradox)","category":{"primary":"personal_care","secondary":"medication","tags":["fertility","IVF","gonadotropin","progesterone","estrogen","endocrine","EDC paradox"]},"product_tier":"BDY","overall_risk_level":"low","description":"Fertility treatment medications including gonadotropins (FSH, LH injections), GnRH agonists/antagonists, progesterone (vaginal, intramuscular), estradiol, and clomiphene. The endocrine disruption paradox: fertility medicine intentionally manipulates the same endocrine pathways that environmental EDCs disrupt. Progesterone in plastic syringes: BPA/phthalate leaching into hormone solution. Multiple medication exposures during IVF cycle: 6-12 different drugs over 2-4 weeks.","synthesis":{"derived_risk_level":"low","synthesis_confidence":0.82,"synthesis_method":"compound_composition","context_used":"human_adult","context_source":"product_users","exposure_modifier":0.977,"vulnerability_escalated":false,"escalation_reason":null,"compounds_resolved":1,"compounds_total":1,"synthesis_date":"2026-03-27","synthesis_version":"1.0.0"},"hazard_summary":{"sensitive_populations":"fertility treatment patients","overall_risk":"low","primary_concerns":["BPA/phthalate leaching from plastic syringes into hormone solutions","Multiple concurrent medication exposures during IVF cycle","EDC paradox: intentional endocrine manipulation while avoiding environmental EDCs","Most fertility medications have decades of established safety data"],"exposure_routes":"Injection, oral, vaginal — multiple routes during treatment"},"exposure":{"routes":["dermal","oral"],"contact_types":["skin_brief","oral_direct"],"users":["adult"],"duration":"minutes","frequency":"daily","scenarios":["Daily hormone injections during IVF stimulation (2-4 weeks)","Progesterone in plastic syringe: potential BPA/phthalate leaching","6-12 different medications during single IVF cycle","Intentional endocrine manipulation vs environmental EDC avoidance"],"notes":"Fertility medications are FDA-approved with established safety profiles for their intended use. The EDC paradox is philosophical: patients avoiding BPA while receiving supraphysiologic estradiol injections. Practical concern: plastic syringes and IV bags may leach BPA into hormone solutions — glass vials preferred where available. Most fertility medications have decades of safety data."},"consumer_guidance":{"usage_warning":"Fertility medications are FDA-approved with established safety profiles. Discuss glass vial options with RE if concerned about plastic syringe leaching. The EDC concern is real but much smaller than the intended hormonal effect. Focus on evidence-based medication choices with your reproductive endocrinologist.","safer_alternatives":["Glass vial preparations where available (reduced plastic leaching)","Discuss medication options with reproductive endocrinologist","Focus on modifiable factors: diet, exercise, sleep, stress reduction","Environmental EDC reduction as complement (not replacement) to fertility treatment"],"red_flags":[{"indicator":"Product not tested for or labeled for specific vulnerable population","meaning":"Standard safety data may not apply to your specific condition.","action":"Consult specialist physician for population-specific guidance."}],"green_flags":[{"indicator":"Physician-recommended or specifically tested for vulnerable population","meaning":"Safety evaluated for your specific condition/life stage.","verification":"Check for condition-specific certifications or physician guidance."}],"what_to_ask":[{"question":"Is this product safe for my specific health condition or life stage?","why_it_matters":"Safety varies dramatically by genetic background, life stage, and health condition.","good_answer":"Evaluated for your specific population with physician input.","bad_answer":"Generic safety data without population-specific consideration."}],"alternatives":[{"name":"Glass vial preparations where available","notes":"reduced plastic leaching"},{"name":"Discuss medication options with reproductive endocrinologist","notes":"Alternative"},{"name":"Focus on modifiable factors: diet, exercise, sleep, stress reduction","notes":"Alternative"}]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"FDA-approved fertility medications","citation":"21 CFR","requirements":"Fertility drugs are FDA-approved prescription medications with established safety/efficacy data.","compliance_status":null,"effective_date":null,"enforcing_agency":"FDA","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":false,"disposal_guidance":"Sharps container for needles. Medication: pharmacy take-back.","hazardous_waste":true,"expected_lifespan":"weeks"},"formulation":{"form":"varies","key_ingredients":[{"hq_id":"hq-c-org-000094","name":"Propylene glycol","role":"formulation_carrier","concentration_pct":"varies"}],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-org-000094","compound_name":null,"role":"formulation_carrier","typical_concentration":"varies"}],"identifiers":{"common_names":["fertility treatment medications (hormones, endocrine disruption paradox)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"Johnson & Johnson","manufacturer":"J&J","market_position":"mass_market","notable":"Broad personal care portfolio"},{"brand":"Unilever","manufacturer":"Unilever","market_position":"mass_market","notable":"Global personal care conglomerate"},{"brand":"Procter & Gamble","manufacturer":"P&G","market_position":"mass_market","notable":"Personal care market leader"}],"sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-25"},{"type":"regulation","title":"FDA-approved fertility medications (21 CFR)","jurisdiction":"USA","citation":"21 CFR","id":"src_faeb618f"},{"id":"fda_pg_cat_food_ban","type":"regulatory","title":"US FDA: Propylene Glycol in Animal Food — Final Rule Prohibiting Use in Cat Food (21 CFR 582.4666) and GRAS Status for Dog Food","year":1996,"inherited_from_compound":"hq-c-org-000094"},{"id":"aspca_apcc_pg","type":"veterinary","title":"ASPCA Animal Poison Control Center: Propylene Glycol — Heinz Body Anemia Risk in Cats and Species Differences in Erythrocyte Sensitivity","year":2022,"inherited_from_compound":"hq-c-org-000094"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-25","timestamp":"2026-05-02T18:17:34.779Z"}}